BDX Becton Dickinson & Co

  1. Stocks
  2. Healthcare
  3. NYSE: BDX

Price (delayed)

$145.52

Market cap

$40.1B

P/E Ratio

36.84

Dividend/share

$48.56

EPS

$3.95

Enterprise value

$56.36B

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 19
Relative Valuation: Rel. Valuation: 51
Relative Profitability: Rel. Profitability: 49

Becton, Dickinson and Company, commonly known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and ...

Highlights
Becton Dickinson's gross profit has increased by 12% YoY and by 3% from the previous quarter
The debt has contracted by 12% from the previous quarter and by 10% YoY
The price to earnings (P/E) is 13% less than the 5-year quarterly average of 42.5 but 10% more than the last 4 quarters average of 33.7
Becton Dickinson's EPS has decreased by 36% QoQ and by 24% YoY
Becton Dickinson's net income has decreased by 35% from the previous quarter and by 24% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.bd.com/
Peers: TMO XRAY ISRG BAX

Key stats

What are the main financial stats of BDX

BDX stock price

How has the Becton Dickinson stock price performed over time
Intraday
-0.49%
1 week
-2.98%
1 month
1.43%
1 year
-15.5%
YTD
-25.02%
QTD
-7.45%

Financial performance

How have Becton Dickinson's revenue and profit performed over time
Revenue
$21.37B
Gross profit
$10B
Operating income
$2.22B
Net income
$1.14B
Gross margin
46.8%
Net margin
5.3%
The net margin has contracted by 36% from the previous quarter and by 29% YoY
Becton Dickinson's net income has decreased by 35% from the previous quarter and by 24% YoY
Becton Dickinson's operating margin has decreased by 13% QoQ
Becton Dickinson's gross profit has increased by 12% YoY and by 3% from the previous quarter

Price vs fundamentals

How does BDX's price correlate with its fundamentals

Growth

What is Becton Dickinson's growth rate over time

Valuation

What is Becton Dickinson stock price valuation
BDX P/E details
P/E
36.84
P/B
1.72
P/S
1.94
EV/EBIT
28.46
EV/EBITDA
12.92
EV/Sales
2.64
Becton Dickinson's EPS has decreased by 36% QoQ and by 24% YoY
The price to earnings (P/E) is 13% less than the 5-year quarterly average of 42.5 but 10% more than the last 4 quarters average of 33.7
The price to book (P/B) is 33% less than the 5-year quarterly average of 2.6 and 14% less than the last 4 quarters average of 2.0
Becton Dickinson's equity has decreased by 4.5% QoQ and by 4.4% YoY
The P/S is 43% lower than the 5-year quarterly average of 3.4 and 19% lower than the last 4 quarters average of 2.4
Becton Dickinson's revenue has increased by 6% YoY

Efficiency

How efficient is Becton Dickinson business performance
Becton Dickinson's return on equity has decreased by 35% QoQ and by 24% YoY
The return on assets has declined by 34% since the previous quarter and by 22% year-on-year
Becton Dickinson's return on sales has decreased by 23% QoQ and by 18% YoY
The return on invested capital has declined by 20% since the previous quarter and by 11% year-on-year

Dividends

What is BDX's dividend history
Dividend details
DPS
$48.56
Dividend yield
33.37%
Payout ratio
1,229.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Becton Dickinson financials performed over time
Becton Dickinson's total assets is 90% more than its total liabilities
Becton Dickinson's quick ratio has decreased by 22% YoY and by 5% QoQ
The current ratio has contracted by 17% YoY and by 10% from the previous quarter
The debt is 28% less than the equity
The debt has contracted by 12% from the previous quarter and by 10% YoY
The debt to equity fell by 6% QoQ and by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.